Subscribe now
AstraZeneca covid-19 vaccine may hinder blood clotting in rare cases

AstraZeneca covid-19 vaccine may hinder blood clotting in rare cases

9 June 2021

Research suggests the Oxford/AstraZeneca coronavirus vaccine is associated with a slightly increased risk of some bleeding disorders, but its benefits continue to outweigh the risks


UK approves Pfizer/BioNTech covid-19 vaccine in children aged 12 to 15

UK approves Pfizer/BioNTech covid-19 vaccine in children aged 12 to 15

4 June 2021

The UK medicines regulator has approved the Pfizer/BioNTech coronavirus vaccine for use in children aged 12 to 15, but the independent vaccination committee has not yet decided whether to extend the roll-out


Global plan aims to make vaccines for future pandemics within 100 days

Global plan aims to make vaccines for future pandemics within 100 days

3 June 2021

Governments and life science industry leaders have pledged to work towards a plan that could see vaccines ready in just 100 days in the event of a new pandemic.


YouTube 'echo chambers' may increase covid-19 vaccine hesitancy

YouTube 'echo chambers' may increase covid-19 vaccine hesitancy

3 June 2021

People who obtain information from social media sites such as YouTube are less willing to be vaccinated than others, findings from a UK study show


Johnson & Johnson one-shot coronavirus vaccine approved for use in UK

Johnson & Johnson one-shot coronavirus vaccine approved for use in UK

28 May 2021

The coronavirus vaccine developed by Johnson & Johnson’s pharmaceutical arm Janssen, which is a single-dose vaccine, has now been approved by the UK medicines regulator


Man in Burkina Faso

Malaria vaccine from Oxford covid-19 team is most effective ever made

23 April 2021

A malaria vaccine produced by the team behind the Oxford/AstraZeneca coronavirus vaccine is 77 per cent effective in trials, offering hope of controlling a disease that kills an estimated 400,000 people each year, many of them children


Novavax coronavirus vaccine found 89 per cent effective in trials

Novavax coronavirus vaccine found 89 per cent effective in trials

29 January 2021

Clinical trials show that a new covid-19 vaccine developed by Novavax is highly effective against a variant of the coronavirus vaccine circulating widely in the UK, but less effective against a variant in South Africa


Vaccination rates have been declining in the UK

The UK has lost its World Health Organization ‘measles-free’ status

19 August 2019

Three years after the measles virus was eliminated, the UK has lost its “measles-free” status, prompting the government to announce urgent action


HPV vaccine to be offered to UK boys as well as girls from September

HPV vaccine to be offered to UK boys as well as girls from September

8 July 2019

11 years after HPV vaccinations for girls started in UK schools, the injection is now set to be offered to boys across the UK too


21 million children miss the first dose of measles vaccine every year

Compulsory vaccines are needed to keep measles under control in the UK

17 May 2019

The UK should make measles vaccinations compulsory before children start school, according to an analysis of international measles data


Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop